![](https://investorshub.advfn.com/uicon/564105.png?cb=1547105359)
Wednesday, May 12, 2021 12:58:34 PM
"Sufficient cash on hand for projected two years of runway, assuming
remaining Medtronic milestones are met in 2021"
So if for any reason MDT hasn't sealed the deal completely by then, we are still funded for operations into April 2023 (presentation date is 4/21/21), with IDE and patient follow-ups all projected to be completed by end of 2022. Therefore, allowing 4 months for the actual FDA application for marketing authorization, we are pretty much funded to the finish line.
On the other hand, the longer MDT waits to close the deal, the more risk they introduce to their own end game, as any other big player could step in with an offer.
No reason to be nervous, for sure!
Message in reply to:
Hard to be too nervous when I read this...
https://d1io3yog0oux5.cloudfront.net/_1b5da01e9503eaa779cd9b3664e79c01/titanmedicalinc/db/1086/9667/pdf/Titan-Medical-Overview-April-21-2021-FINAL.pdf
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM